Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept Induction and Maintenance in Active Crohn's Disease
NCT00406653Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2006
- Primary completion
- Nov 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 17
01
Overview
A Phase 3 trial of abatacept in Crohn's disease, sponsored by Bristol Myers Squibb. Started Dec 2006; status: terminated.
02
Drugs
abatacept
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00406653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406653.